Drugs / Hepatitis B vaccination
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03951870 Background | Jan 2019 → Aug 2022 | autoimmune hepatitis | Tel-Aviv Sourasky Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis B vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03951870 ↗ |
| Modality | Vaccine | “immune challenge with the hepatitis B virus (HBV) vaccine and assessments of HBV antibody (HBVab) levels.” PMID 41555034 ↗ Jan 2026 |